FDA takes keen interest in Pfizer's maraviroc scandal.

Pfizer has claimed publicly that the FDA will approve Pfizer's HIV drug maraviroc on June 20 and launch the drug in July.

So perhaps it isn't surprising that the FDA takes a keen interest in the maraviroc whistleblower stories on this blog. And even less surprising if the whole situation gives Pfizer ants in their pants.

Parklawn Computer Center is the label for FDA's IP address, (confirm here).

You can find the most recent maraviroc whistleblower stories here.